BeStock  
Stocks › Biotechnology › AGIO

Agios Pharmaceuticals AGIO

US equityMarket cap rank #2826Biotechnology
$31.25 −$0.55 (-1.73%)
Pre-market · Oct 6, 4:10 am ET · After hours $31.25 0.00%
Open$31.65
Prev close$31.80
Day range$30.78 – $31.76
Volume808.7K
Market cap$1.87B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-4.5x
CheapRich

Around its usual level · 57th percentile, 5-year average -3.2x

Price / book1.8x
CheapRich

Above its usual level · 77th percentile, 5-year average 1.7x

#2723 of 5315 stocks by PB (1 = cheapest)

Price / sales19.0x
CheapRich

Near the bottom of its 5-year range · 12th percentile, 5-year average 136.5x

#4656 of 5147 stocks by PS (1 = cheapest)

P/E over five years

-14x-7x0x6xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$53.12
Price vs. fair value-41.2%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 1.82 – 1.65 77% (pricier than usual) #2723 of 5315 (1 = cheapest)
PE -4.46 -7.30 -3.23 57% (pricier than usual) –
PS 18.97 6.95 136.51 12% (cheaper than usual) #4656 of 5147 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★★
Fair value estimate$53.12
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on AGIO.

Leave a comment

Scroll to Top